PREFERENTIAL INHIBITION OF ACETYLCHOLINESTERASE MOLECULAR-FORMS IN RAT-BRAIN

被引:32
作者
OGANE, N
GIACOBINI, E
MESSAMORE, E
机构
[1] Department of Pharmacology, Southern Illinois University School of Medicine, Springfield, 62794-9230, Illinois
关键词
ACETYLCHOLINESTERASE (ACHE); MOLECULAR FORMS; ACHE INHIBITORS; HEPTYL-PHYSOSTIGMINE; SUCROSE DENSITY GRADIENT SEDIMENTATION;
D O I
10.1007/BF00969897
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The effect of eight different acetylcholinesterase inhibitors (AChEIs) on the activity of acetylcholinesterase (AChE) molecular forms was investigated. Aqueous-soluble and detergent-soluble AChE molecular forms were separated from rat brain homogenate by sucrose density sedimentation. The bulk of soluble AChE corresponds to globular tetrameric (G4), and monomeric (G1) forms. Heptyl-physostigmine (HEP) and diisopropylfluorophosphate were more selective for the G1 than for the G4 form in aqueous-soluble extract. Neostigmine showed slightly more selectivity for the G1 form both in aqueous- and detergent-soluble extracts. Other drugs such as physostigmine, echothiophate, BW284C51, tetrahydroaminoacridine, and metrifonate inhibited both aqueous- and detergent-soluble AChE molecular forms with similar potency. Inhibition of aqueous-soluble AChE by HEP was highly competitive with Triton X-100 in a gradient, indicating that HEP may bind to a detergent-sensitive non-catalytic site of AChE. These results suggest a differential sensitivity among AChE molecular forms to inhibition by drugs through an allosteric mechanism. The application of these properties in developing AChEIs for treatment of Alzheimer disease is considered.
引用
收藏
页码:489 / 495
页数:7
相关论文
共 34 条
[1]   ARE SOLUBLE AND MEMBRANE-BOUND RAT-BRAIN ACETYLCHOLINESTERASE DIFFERENT [J].
ANDRES, C ;
ELMOURABIT, M ;
STUTZ, C ;
MARK, J ;
WAKSMAN, A .
NEUROCHEMICAL RESEARCH, 1990, 15 (11) :1065-1072
[2]   MOLECULAR-FORMS OF ACETYLCHOLINESTERASE IN SENILE DEMENTIA OF ALZHEIMER TYPE - SELECTIVE LOSS OF THE INTERMEDIATE (10S) FORM [J].
ATACK, JR ;
PERRY, EK ;
BONHAM, JR ;
PERRY, RH ;
TOMLINSON, BE ;
BLESSED, G ;
FAIRBAIRN, A .
NEUROSCIENCE LETTERS, 1983, 40 (02) :199-204
[3]   MECHANISMS OF CHOLINESTERASE INHIBITION IN SENILE DEMENTIA OF THE ALZHEIMER TYPE - CLINICAL, PHARMACOLOGICAL, AND THERAPEUTIC ASPECTS [J].
BECKER, RE ;
GIACOBINI, E .
DRUG DEVELOPMENT RESEARCH, 1988, 12 (3-4) :163-195
[4]   CHANGE IN THE DISTRIBUTION OF ACETYLCHOLINESTERASE MOLECULAR-FORMS IN FRONTOPARIETAL CORTEX OF THE RAT FOLLOWING NUCLEUS BASALIS LESIONS WITH KAINIC ACID [J].
BISSO, GM ;
DIANA, G ;
FORTUNA, S ;
MENEGUZ, A ;
MICHALEK, H .
BRAIN RESEARCH, 1988, 449 (1-2) :391-394
[5]   ACTIVE MONOMERIC FORM OF ELECTROPHORUS-ELECTRICUS ACETYLCHOLINESTERASE [J].
BON, S ;
MASSOULIE, J .
FEBS LETTERS, 1976, 67 (01) :99-103
[7]   ANTICHOLINESTERASE ACTIVITY OF A NEW CARBAMATE, HEPTYLPHYSOSTIGMINE, IN VIEW OF ITS USE IN PATIENTS WITH ALZHEIMER-TYPE DEMENTIA [J].
BRUFANI, M ;
MARTA, M ;
POMPONI, M .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1986, 157 (01) :115-120
[8]  
CHANGEUX JP, 1966, MOL PHARMACOL, V2, P369
[9]   THE EFFECT OF HEPTYL-PHYSOSTIGMINE, A NEW CHOLINESTERASE INHIBITOR, ON THE CENTRAL CHOLINERGIC SYSTEM OF THE RAT [J].
DESARNO, P ;
POMPONI, M ;
GIACOBINI, E ;
TANG, XC ;
WILLIAMS, E .
NEUROCHEMICAL RESEARCH, 1989, 14 (10) :971-977
[10]  
DIGIAMBERARDINO L, 1978, NATURE, V271, P170